RESOLUTE JAPAN SVS: The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries.
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Zotarolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders; Myocardial ischaemia; Unstable angina pectoris
- Focus Therapeutic Use
- Acronyms RESOLUTE Japan SVS
- Sponsors Medtronic
- 13 Sep 2016 Status changed from active, no longer recruiting to completed.
- 06 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jun 2010 New trial record